VEGFA and age-related macular degeneration: Results demonstrate that the frequency of homozygous ‘CC’ and heterozygous ‘CT’ of B3GALTL are more frequent in AMD patients, being moderate and non-responsive towards anti-VEGF response with context to number of injections given to the patients.